Impact on Quality of Life of Osteopathic Visceral Mobilizations After Endometriosis Surger
One of the most common post-operative complications of gynaecological surgery, and in particular endometriosis surgery, is the formation of peritoneal adhesions. After laparotomy, it affects up to 90% of patients. Minimally invasive techniques (such as laparoscopy) reduce the risk of adhesion formation, but cannot tota
| Condition(s) | Endometriosis, Osteopathy in Diseases Classified Elsewhere |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | One of the most common post-operative complications of gynaecological surgery, and in particular endometriosis surgery, is the formation of peritoneal adhesions. After laparotomy, it affects up to 90% of patients. Minimally invasive techniques (such as laparoscopy) reduce the risk of adhesion formation, but cannot totally prevent it. Adhesions can lead to chronic pelvic pain, dyspareunia, digestive disorders and infertility. Various strategies and devices have been developed to try and limit adhesion formation, but their effectiveness has not been fully proven in the literature. The only real treatment for adhesions is adhesiolysis, although adhesions often reform. The quality of surgery remains the best means of preventing adhesion formation. To reduce the morbidity associated with pelvic |
| Who can participate | Inclusion Criteria: * Woman of legal age * Indication for surgery for infiltrating endometriosis * Able to give informed consent to participate in research * Patient included in NO ENDO (national endometriosis observatory promoted by Clermont-Ferrand University Hospital) Exclusion Criteria: * Indication for surgery for superficial endometriosis * Patient of legal age, under guardianship or trusteeship * Pregnant or breast-feeding patient * Patients not affiliated to the social security system * Patients who do not speak French * Patients under court protection * Simultaneous participation in another study * Refusal to participate. |
| Ages | 18 Years |
| Sex | Female |
| Lead sponsor | University Hospital, Clermont-Ferrand |
| Locations | Clermont-Ferrand, France |
| Start date | 2025-01-27 |
| NCT ID | NCT06553989 |
| Official listing | https://clinicaltrials.gov/study/NCT06553989 |